Some of our recent recommendations are exploding.
For example, on July 2, we again highlighted opportunity in Teladoc Health (TDOC) as it traded at $202.79. As of this morning, the stock is set to open at $220, and could easily run to $250, near-term in our opinion. All as the telehealth boom continues with mounting COVID cases.
On June 29, we highlighted Square (SQ) as it traded at $103.68. It’s now up to $119.
On June 25, we highlighted Novavax (NVAX) as it traded at $81.31. This morning, NVAX is set to open at $107.45 after announcing a $1.6 billion contract to develop a vaccine under the White House’s “Operation Warp Speed” program.
If you’re in these trades, we’d love to hear how you’re doing so far.
This morning, we’re not seeing anything worth getting excited about. In fact, with the Dow set to drop nearly 300 points this morning, it’s a good idea to just sit on the sidelines. Issuing a trade recommendation for the sake of issuing a trade recommendation is a great way to lose money. And that’s the last thing we want to do.